Clinical Trial Update: Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(A), US-NovoLog®, and EU-NovoRapid® [Phase 1]

View source ↗

Summary

Phase 1 study completed to demonstrate pharmacokinetic and pharmacodynamic similarity between NKF-INS(A) and reference insulins US-NovoLog and EU-NovoRapid in h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• EU-NovoRapid® (insulin aspart)
• NKF-INS(A)
• US-NovoLog® (insulin lispro)

Snippet

Sponsor: Xentria, Inc. | Conditions: Healthy Participants | Phase 1 | Status: COMPLETED | Results posted: 2026-01-21